Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Share News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Horizon Discovery Land Commercial Deals With TrueBinding

Wed, 29th Jul 2020 15:45

Horizon Discovery Group PLC - Gene editing company based in Cambridge - Signs set of commercial license agreements for CHOSOURCE gene editing platform with biopharmaceutical firm TrueBinding Inc. TrueBinding to use platform to help further its medication in immuno-oncology and other fields with "unmet medical need".

Current stock price: 103.50 pence

Year-to-date change: down 31%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2020 14:03

UK TRADING UPDATE SUMMARY: John Menzies Axes 17,500 Jobs Amid Covid-19

UK TRADING UPDATE SUMMARY: John Menzies Axes 17,500 Jobs Amid Covid-19

Read more
23 Mar 2020 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
4 Feb 2020 12:55

Horizon Discovery Reports "Solid" 2019 Ahead Of US Public Offering

Horizon Discovery Reports "Solid" 2019 Ahead Of US Public Offering

Read more
4 Feb 2020 08:34

Horizon Discovery revenues grow following strong FY performance

(Sharecast News) - Gene editing and modulation firm Horizon Discovery expects full-year revenues to show some year-on-year improvement after a strong performance from its research reagents and screening business units.

Read more
14 Jan 2020 13:48

Horizon Discovery Exercises Option To License Base Editing Technology

Horizon Discovery Exercises Option To License Base Editing Technology

Read more
13 Dec 2019 09:34

Horizon Discovery Pens Joint Venture With US DNA Researchers Mammoth

Horizon Discovery Pens Joint Venture With US DNA Researchers Mammoth

Read more
13 Dec 2019 08:27

Horizon Discovery inks strategic partnership with Mammoth Biosciences

(Sharecast News) - Life sciences firm Horizon Discovery has signed a strategic collaboration deal with Mammoth Biosciences that will see the two companies develop new clustered regularly interspaced short palindromic repeat (CRISPR) tools.

Read more
8 Nov 2019 12:09

Horizon Discovery offloads In Vivo business to Envigo

(Sharecast News) - Gene editing and gene modulation technology company Horizon Discovery Group announced an agreement to divest its In Vivo business unit to Envigo RMS on Friday, for a nominal consideration satisfied in cash.

Read more
8 Nov 2019 11:59

Horizon Discovery Sells "Subscale" Unit In Vivo For Nominal Sum

Horizon Discovery Sells "Subscale" Unit In Vivo For Nominal Sum

Read more
8 Nov 2019 11:54

Friday broker round-up

(Sharecast News) - Tate & Lyle: Kepler Cheuvreux upgrades to hold with a target price of 720p.

Read more
16 Sep 2019 11:44

Horizon Discovery Loss Narrows On Bioproduction And Screening Revenue

(Alliance News) - Horizon Discovery Group PLC on Monday said its loss narrowed in the first half of 2019, helped by strong performance from Bio-production and Screening business revenue surged to

Read more
9 Sep 2019 16:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 10 SeptemberĀ Gulf KeystoneHalf Year ResultsTP GroupHalf Year GroupHalf

Read more
19 Jun 2019 18:29

Woodford Investment Cuts Stake In NewRiver REIT, Horizon Discovery

(Alliance News) - NewRiver REIT PLC said embattled fund manager Woodford Investment Management Ltd has cut stake in the company to 12.8% from 14.9% on Tuesday.Separately, Horizon Discovery

Read more
11 Jun 2019 16:06

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 12 JuneFilta GroupHC SlingsbyGANLondon & Associated 13 Morrison Jack 14

Read more
25 Apr 2019 17:42

Invesco Reduces Holding In Horizon Discovery Group To 4.4% (ALLISS)

LONDON (Alliance News) - Horizon Discovery Group PLC said on Thursday that Invesco Ltd has reduced its interest in the company to 4.4% from 9.9% in a deal on Tuesday.Shares in the gene 1.1%

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.